Novartis: Drug Regulation Must Not Block New Drugs (Reuters


Reuters - Tighter drug regulation triggered by
recent safety scandals must not be allowed to block innovation
and the introduction of new medicines, the head of
Switzerland's Novartis AG said on Friday.

Read more...